Murine gammaherpesvirus causes an acute respiratory infection followed by a latent infection in B lymphocytes. In the first 2-3 weeks after infection mice develop a marked splenomegaly, where the spleen cell number increases by 2-3-fold. Cytofluorimetric analysis during splenomegaly revealed an increase in numbers of B lymphocytes and of both CD4 + and CD8 + T lymphocytes. The largest increase relative to uninfected spleens was in the CD8 + population. The number of latently infected cells in the spleen peaked at day 10 post-intraperitoneal infection, then declined to 1/106-1/107 cells per spleen. Depletion of CD4 + T lymphocytes prevented the splenomegaly and greatly reduced the peak infective centre level, while having no effect on the long-term level of latently infected cells. Given the similarity between MHV-68-induced splenomegaly and Epstein-Barr virus-induced infectious mononucleosis, these data highlight the usefulness of MHV-68 as a mouse model for the study of gammaherpesvirus immunology and pathobiology.
Murine gammaherpesvirus (MHV-68) was first isolated from a bank vole in Slovakia (Blastovik et al., 1980) ; studies on genome organization combined with limited sequence analysis revealed homology to the gammaherpesviruses (Efstathiou et al., 1990a, b) . After experimental intranasal infection of mice with MHV-68 the virus replicates in the lung for 7-10 days, then free virus is rapidly cleared (Sunil-Chandra et al., 1992a) . The infection spreads to the spleen, where latent virus can be detected predominantly within the B lymphocyte population (Sunil-Chandra et al., 1992b) . Latency within B lymphocytes is characterized by a lack of detectable virus antigen expression, but virus genome can be detected using molecular techniques. A dramatic splenomegaly occurs at 14 days post-infection, which then declines over the next 14 days; 18-24 months after infection some 10% of infected mice develop lymphoproliferative disease, and 50 % of these have high-grade lymphomas (Sunil-Chandra et al., 1994) . Given the striking pathobiological similarities between MHV-68 infection of mice and EpsteimBarr virus (EBV) infection of humans, this system appears to be a promising animal model for studying human gammaherpesvirus infection.
The marked splenomegaly observed shortly after MHV-68 infection was of interest, as there are parallels with infectious mononucleosis seen upon primary in-* Author for correspondence. Fax +44 131 650 6511. e-mail EJU@lab0.vet.ed.ac.uk fection with EBV. During the splenomegaly there is a large increase in the number of latently infected spleen cells (Sunil-Chandra et al., 1992a, b) , the significance of which in the pathology is unclear. Lymphocyte depletion experiments reported previously (Ehtisham et al., 1993) showed that in the absence of CD8 + T cells infected mice were unable to clear the lung infection. CD4 + subset depletion had a less dramatic effect and virus clearance was merely delayed by 3-4 days. Events occurring in the spleen were less well-studied, although splenomegaly was reduced in the CD4-depleted group, and there was no enlargement of germinal centres in the spleen (Ehtisham et al., 1993) . Studies reported here were directed towards analysing which lymphocyte subsets were expanded during splenomegaly, and the effect of CD4 ÷ T lymphocyte depletion on the rise and fall of latently infected cells in the spleen.
Two groups of BALB/c mice were infected with 5 x 105 p.f.u. MHV-68 by the intraperitoneal route; one group was treated with anti-CD4 depleting monoclonal antibody YTS 191 (Cobbold et al., 1984) , and the other with PBS. The intraperitoneal route was used in preference to the more usual intranasal route as this results in a more vigorous spleen infection and a pronounced splenomegaly. As shown in Fig. 1 , there was a 2-3-fold increase in total spleen cell number at 10 days post-infection in the immunocompetent group; however, the CD4 depleted group exhibited little or no increase in the number of spleen cells. Histological analysis revealed a large increase in the size of splenic germinal centres 0001-3679 © 1996 SGM during splenomegaly, with a preponderance of large, activated lymphocytes (data not shown). Following the peak splenomegaly the cell number decreased towards normal levels.
To determine the phenotype of ceils present during the course of splenomegaly spleen cells taken at various times post-infection were stained with monoclonal antibodies against CD4, CD8 and B220 followed by an FITC-labelled secondary antibody. Samples were analysed using a Becton-Dickinson FACScan with a lymphocyte gate. Knowledge of the percentage of each cell subset in the sample and the total spleen cell number allowed the total number in each subset to be calculated. This was then compared with the numbers for these subsets in uninfected mice (determined from the average of five mice stained simultaneously with the test samples); the percentage increase in each subset is presented in Fig.  2 . There was a marked increase in all three subsets during the splenomegaly: at day 10 this represented a 2.5-fold increase over normal levels. The largest difference was observed in the CD8 subset, which exhibited a 4.5-fotd increase. The increase in the CD8 and B lymphocyte subsets paralleled the development of splenomegaly; however, the CD4 cell increase was more gradual, peaking at day 16 post-infection.
Following infection, latently infected B cells present in the spleen give rise to infective centres when spleen cells are co-cultivated with permissive BHK cells (SunilChandra et al., 1992a) . Spleens from infected mice were dissociated, the red blood cells lysed and a set number of cells cultured with 2 x l0 G BHK cells in 60 mm Petri dishes; 5 days later the plates were fixed and stained with 0-1% toluidine blue for plaque enumeration. Fig. 3 shows the profile of infective centres in immunocompetent mice and in mice depleted of CD4 T cells. A high level of infective centres was present at days 7 and 10 in the immunocompetent mice; this then rapidly declined and at late times post-infection only 1 / 106-1 / 107 spleen cells gave rise to infective centres. The initial rise in infective centres was much reduced in the CD4-depleted group, and at the peak approximately 5-fold more infective centres were detected in the immunocompetent group, which represents a significant difference between the two groups (P < 0-05). This was not due to a non-specific effect of a high dose of monoclonal antibody, as treatment of mice with a depleting anti-CD8 antibody of the same isotype had no effect on the day 10 infective centres (numbers of infective centres per spleen were: immunocompetent mice, 1.29 x 104_+3.09 x 103; CD8 depleted mice, 1.53 x 10~_+4-92x 10 a) or spleno- megaly (numbers ofsplenicleukocytes were: immunocompetent mice, 2.35 x 10 s -t-2-05 x 107; CD8 depleted mice, 2-04 x 108 + 6.04 x 107). At later times post-infection (from day 30 to day 81) no consistent difference was detected between the two groups, suggesting that the absence of CD4 T lymphocytes does not affect the longterm level of latently infected cells. Free virus was consistently detected in the spleens of CD4-depleted mice at 10 days post-infection, albeit at a much lower level than the infective centres at this timepoint (55 _+ 24 p.f.u, per spleen); however, free virus was either undetectable or on the limit of detection of the assay (5 10p.f.u. per spleen) in the spleens from immunocompetent mice. Similar results were obtained at 7 days post-infection, and little or no free virus was detectable in either group after day 10.
Infection of mice with MHV-68 results in splenomegaly and the establishment of viral latency in B lymphocytes. In this paper we analysed the lymphocyte population during splenomegaly and the effect of T lymphocytes on the infection of B cells. We have shown that splenomegaly results in an increase in splenic B and T lymphocytes, in particular CD8 T cells which increased to over 450 % above normal spleen levels. Splenomegaly results from the activity of CD4 + T cells, which also influence the numbers of latently infected B cells seen during the second week after infection. For reasons detailed above the intraperitoneal route of infection was used for these experiments, but previous work from this laboratory indicates that similar effects are seen when infection occurs by the intranasal route (Ehtisham et al., 1993) .
The large increase of mononuclear cells consisting mostly of an expansion in the CD8 + subset is strongly reminiscent of EBV-induced infectious mononucleosis (IM). Several reports have shown that during IM the percentage of peripheral blood CD8 + lymphocytes increases while the percentage of CD4 + lymphocytes decreases (Reinherz et al., 1980; De Waele et al., 1981) . Both CD4 ÷ and CD8 + subsets are activated, as determined by the upregulation of surface CD45RO (Miyawaki et al., 1991) , and EBV-specific cytotoxic T lymphocytes (CTLs) can be detected (Svedmyr & Jondal, 1975; Royston et al., 1975) . IM is usually self-limiting, and the relative levels of CD4 + and CD8 + T cells return to normal during convalescence (Reinherz et al., 1980) . It would appear that in both IM and MHV-68-induced splenomegaly there is a substantial activation of the T cell compartment, which leads to extensive lymphocyte proliferation, presumably through the action of cytokines secreted by CD4 + T cells. Recent work in this laboratory has shown that splenomegaly is not observed following MHV-68 infection of transgenic mice with a deletion in the g immunoglobulin chain, in which B cell development is arrested at the pre-B cell stage (unpublished observations). Thus B lymphocytes are also required for the development of splenomegaly. This may reflect a requirement for antigen presentation by infected B cells, rather than macrophages or dendritic cells, to specific CD4 + T cells.
EBV-transformed human B cells will cause fatal lymphoproliferative disease when transferred into a nonimmune environment such as a mouse with severe combined immunodeficiency (SCID) (Rowe et al., 1991) , but only when T cells are also transferred (Veronese et al., 1992) . Similarly, the load of MHV-68 infected B cells rises during splenomegaly, but is dependent on T cell help. Whether this increase reflects a selective expansion of latently infected cells over uninfected cells or that infected cells are merely expanding at the same rate as the total B cell pool is unclear.
The rapid fall in numbers of infective centres after day 10 is intriguing. It may reflect CTL clearance of infected cells expressing certain viral antigens, but those failing to express these antigens, due to a different form of latency, survive so the infection is not completely cleared. Preliminary evidence from this laboratory supports this hypothesis, as mice depleted of CD8 + T cells have higher infective centre levels than immunocompetent mice during the clearance phase (unpublished data). This may also explain why higher free virus titres were detected in CD4 + depleted mice, as B cells which would go on to reactivate may be Iysed by CTLs in intact mice when they start to express viral antigens, whereas in immunocompromised animals the cells survive and go on to release virus. An alternative hypothesis is that lymphocytes activated during splenomegaly go on to die by apoptosis. Lymphocytes from patients with IM die by apoptosis when cultured in vitro, and this appears to be related to their activated state and down-regulation of the anti-apoptotic bcl-2 molecule (Uehara et al., 1992; Akbar et al., 1993) .
In conclusion we have shown that complex T-B lymphocyte interactions are necessary for the development of splenomegaly after MHV-68 infection. These events have a large effect on the number of latently infected cells in the spleen; however, an early expansion in infected cell numbers is not required for long-term virus survival in the host. 
